Certificate number:RU.77.99.88.003.E.000354.01.18
Date of registration and renewal:26.01.2018
Dosage form: & nbspChewing lozenges weighing 2500.0 mg for sale to the public; in the "in bulk" package for subsequent packaging in consumer packaging
Classification "Composition" & nbsp BADs - fats, fatty substances and their derivatives Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp Supplements containing calcium and phosphorus
Composition: & nbspThe starch is starchy; sugar; premix "MixMe Calcium" (calcium phosphate, E330, maltodextrin, natural food flavor (or strawberry, or raspberry, or cherry, or currant, or forest berries), cholecalciferol, phytomenadione, E120), gelatin, concentrated apple juice; lemon acid; complex food additive Capol® (vegetable oil, carnauba wax); refined sunflower oil.
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of calcium, vitamins: D3, K1. In the "in bulk" package for subsequent packaging in consumer packaging.
Suggested Usage: & nbspTake children from 3 years and adults - 1 lozenges 2 times a day with meals. Duration of admission is 1 month. If necessary, the reception can be repeated,
Contraindications:Individual intolerance of components, violation of carbohydrate metabolism, diabetes mellitus, excess body weight.
Special instructions:Before use, it is recommended to consult a doctor. Before applying dietary supplements, children are advised to consult a pediatrician.
Shelf life:18 months.
Storage conditions:Store in the original packaging in a dry place protected from light and inaccessible to children at a temperature not exceeding + 25 ° С; after opening the package, store at a temperature of 15 ° C to 25 ° C and at a relative humidity of 40-60% for 60 days.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.88.003.Е.000163.01.18 of 19.01.2018; expert opinion of FGBUN "FIC of nutrition and biotechnology" No. 529 / E-1096 / b-17 of December 21, 2017.
Recipient:Vneshtorg Pharma, LLC Vneshtorg Pharma, LLC Russia
Information update date: & nbsp22.03.2018
Instructions
Up